Slide 1

 

Slide 2

 

Slide 3

 

Slide 4

 

Slide 5

Ongoing Phase 1/2a to Establish Broad Therapeutic Window for Bamzireotide Navoxetan

Slide 6

 

Slide 7

 

Slide 8

 

Slide 9

 

Slide 10

 

Slide 11

 

Slide 12

 

Slide 13

 

Slide 14

 

Slide 15

 

Slide 16

 

Slide 17

 

Slide 18

 

Slide 19

 

Slide 20

 

Slide 21

 

Slide 22

 

Slide 23

 

Slide 24

 

Slide 25